EUROFINS DISCOVERX LLC

Eurofins DiscoverX Corporation specializes in advanced biological testing and laboratory services, with a focus on high-throughput screening, assay development, and pharmacological paneling for research and regulatory applications. Their core capabilities center on precision life sciences testing, including cell-based assays, receptor profiling, and functional genomics platforms used to evaluate drug candidates and biological pathways. The company leverages proprietary screening technologies and standardized paneling services to deliver reproducible, data-rich results critical to early-stage drug discovery and toxicology studies. Their technical expertise lies in automating complex biological workflows, ensuring compliance with Good Laboratory Practices, and integrating multi-omics data into actionable insights for pharmaceutical and biomedical clients. The contractor has demonstrated direct engagement with the Department of Veterans Affairs, providing specialized testing services that support veteran health research initiatives, likely involving pharmacological screening or biomarker validation for chronic conditions prevalent in veteran populations. This relationship suggests alignment with VA’s mission to advance evidence-based therapeutics and personalized medicine through rigorous laboratory validation. Eurofins DiscoverX operates primarily within NAICS 541380, which encompasses testing laboratories and services focused on biological, chemical, and environmental analysis. Their market positioning is in the niche of preclinical drug development support, serving biopharmaceutical and government-funded research entities that require validated, scalable testing infrastructure. They are not broadly engaged across multiple NAICS categories, indicating a focused specialization in life sciences testing rather than broad-spectrum laboratory services. As a 2L entity based in Fremont, California, the company maintains a lean, technically driven structure optimized for high-compliance laboratory operations. While no government certifications are listed, their work implies adherence to GLP, CLIA, and potentially ISO 17025 standards through routine federal contract performance. Their geographic presence in the Bay Area positions them within a dense ecosystem of biotech innovation and federal research partnerships.